Skip to main content
. 2015 May 8;6(19):17237–17250. doi: 10.18632/oncotarget.4044

Figure 3. Localization of PGAM with the use of antibody against the C-terminal peptide in neoplastically transformed (NSCLC, KLN-205) and non-malignant (HL-1 cardiomiocytes, astrocytes) cells cultured in serum-free media.

Figure 3

Bar=10 μm.